Travanti Pharma Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Travanti Pharma General Information
Description
Provider of drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medications, which are delivered into the body. The company's technology platforms include Electronic drug delivery, a non-invasive technology that utilizes controlled low-level electrical energy to transport drugs through the skin or other sites in the body in a safe manner; and Wearable Electronic Disposable Drug delivery technology, which is a portable and disposable electronic transdermal drug delivery system.
Contact Information
Website
www.travantipharma.comCorporate Office
- 2520 Pilot Knob Road
- Suite 100
- Mendota Heights, MN 55120
- United States
Corporate Office
- 2520 Pilot Knob Road
- Suite 100
- Mendota Heights, MN 55120
- United States
Travanti Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 08-May-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 30-Jun-2006 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 24-Jan-2005 | $1.73M | $1.73M | Completed | Product Development |
Travanti Pharma Patents
Travanti Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2010229336-A1 | Medication disposal system | Inactive | 26-Mar-2009 | ||
| WO-2010110837-A1 | Medication disposal system | Inactive | 26-Mar-2009 | ||
| WO-2010027468-A1 | Iontophoretic drug delivery packaging | Inactive | 05-Sep-2008 | ||
| WO-2010027444-A1 | Sacrificial electrode design and delivery species suitable for prolonged iontophoresis application periods | Inactive | 02-Sep-2008 | ||
| WO-2007120747-A2 | Transdermal methods and systems for the delivery of anti-migraine compounds | Inactive | 13-Apr-2006 | A61K9/7038 |
Travanti Pharma Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pinnacle Investment Management | Asset Manager | Majority | ||
| Prolog Ventures | Venture Capital | Minority | ||
| Space Center Ventures | Venture Capital | Minority | ||
| Spring Bay Companies | Family Office | Minority |
Travanti Pharma FAQs
-
When was Travanti Pharma founded?
Travanti Pharma was founded in 1997.
-
Where is Travanti Pharma headquartered?
Travanti Pharma is headquartered in Mendota Heights, MN.
-
What industry is Travanti Pharma in?
Travanti Pharma’s primary industry is Drug Delivery.
-
Is Travanti Pharma a private or public company?
Travanti Pharma is a Private company.
-
What is Travanti Pharma’s current revenue?
The current revenue for Travanti Pharma is .
-
How much funding has Travanti Pharma raised over time?
Travanti Pharma has raised $9.5M.
-
Who are Travanti Pharma’s investors?
Pinnacle Investment Management, Prolog Ventures, Space Center Ventures, and Spring Bay Companies have invested in Travanti Pharma.
-
When was Travanti Pharma acquired?
Travanti Pharma was acquired on 08-May-2009.
-
Who acquired Travanti Pharma?
Travanti Pharma was acquired by Teikoku Pharma USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
